Which one of the following is ineffective in acute iron toxicity :
**Core Concept**
Iron toxicity occurs when excessive iron is ingested, leading to cellular damage and oxidative stress. The body's response to iron toxicity involves the formation of reactive oxygen species (ROS) that cause tissue damage.
**Why the Correct Answer is Right**
In acute iron toxicity, administering deferoxamine (also known as desferoxamine) is ineffective because it is a chelating agent that works well in the context of chronic iron overload, not acute toxicity. Deferoxamine binds to iron in a 1:1 ratio and is excreted in the urine, making it useful for treating conditions like hemochromatosis. However, in acute iron toxicity, the rapid release of iron from the gut or other sources overwhelms the body's ability to excrete it, making deferoxamine ineffective.
**Why Each Wrong Option is Incorrect**
**Option A:** Not applicable, as the question asks for an ineffective treatment.
**Option B:** Deferasirox is a newer iron chelator that is effective in acute iron toxicity, especially in cases where deferoxamine is not tolerated.
**Option C:** Succimer is a chelating agent used primarily for lead poisoning and is not effective in acute iron toxicity.
**Clinical Pearl / High-Yield Fact**
In the context of acute iron toxicity, administering activated charcoal within 1 hour of ingestion can be beneficial in reducing iron absorption and preventing further toxicity. However, once iron has been absorbed, treatment focuses on chelation therapy.
**Correct Answer:** A.